Critics of gender-affirming care for minors made their case at a day-long workshop before a Federal Trade Commission (FTC) that, under the Trump administration, has warmed to their views.

Companies that can't back up claims that their products are made in the U.S. could face hefty penalties from the Federal Trade Commission.

A U.S. judge formally admonished Amazon.com on Thursday for withholding documents from the U.S. Federal Trade Commission in a lawsuit accusing the e-commerce giant of deceiving customers of its paid Prime service.

The FTC has an "unequivocal basis" to investigate the transgender medicine industry, Commissioner Mark Meador says.

The Federal Trade Commission is weighing whether certain gender-affirming care practices are deceptive and need greater scrutiny, the agency’s leader said Wednesday.

The daylong invite-only workshop features detransitions, parents, regulators and scientific experts on puberty blockers, cross-sex hormones and surgery for gender-confused youth.

Doctors who pitched medical treatments to minors with gender dysphoria may have deceived them, according to the Federal Trade Commission.

Many companies have been accused by regulators of using imprecise labeling to induce shoppers to pay more through appeals to their patriotism.